Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

LENZ Therapeutics Inc (LENZ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow LENZ Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
29.33 -0.63    -2.10%
04/08 - Closed. Currency in USD
Pre Market
30.55
+1.22
+4.16%
10:11:54 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 381,939
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 27.79 - 31.20
LENZ Therapeutics 29.33 -0.63 -2.10%

LENZ Therapeutics Inc Company Profile

 
Get an in-depth profile of LENZ Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

11

Equity Type

ORD

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Contact Information

Address 201 Lomas Santa Fe Drive Suite 300
Solana Beach, 92075
United States
Phone (858) 925-7000
Fax -

Top Executives

Name Age Since Title
Carolyn Majcher - - Member of Advisory Board
Jim Mccollum - - -
Evert B. Schimmelpennink 53 2021 President, CEO, Secretary & Director
John Doane - - Member of Medical Advisory Board
Jeffrey P. George 51 2024 Independent Chairman
Shelley B. Thunen 71 2024 Independent Director
James W. McCollum 69 2024 Co-Founder & Director
Steven J. Dell - - Member of Medical Advisory Board
Colman Kraff - - Member of Medical Advisory Board
Frederic Guerard 52 2024 Independent Director
Zachary Scheiner 48 2020 Independent Director
Robert H. Osher - - Member of Medical Advisory Board
Kimberlee Cobleigh Drapkin 57 2023 Independent Director
Michael Kling - - Member of Advisory Board
Kathryn Hatch - - Member of Medical Advisory Board
Deepinder Dhaliwal - - Member of Medical Advisory Board
Andrew Morgenstern - - Member of Advisory Board
S. Barry Eiden - - Member of Advisory Board
Louise Sclafani - - Member of Advisory Board
Stephanie Woo - - Member of Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LENZ Comments

Write your thoughts about LENZ Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email